OKYO Pharma Ltd (NASDAQ:OKYO) a clinical-stage biopharmaceutical company focused on therapies for neuropathic corneal pain ...

The Wabash Valley Audubon Society will host retired educator Mike Lunsford for Mr. Hitchcock's Crow Show, a presentation about legendary director Alfred Hitchcock's classic film, 'The Birds' at 6:30 p ...

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye ...

MCLEAN, VA / ACCESS Newswire / February 3, 2026 / Gladstone Investment Corporation (Nasdaq:GAIN) (the “Company”) today ...

LYON—As part of the next phase of the EU’s SESAR program for air traffic management (ATM) research and technology, Eurocontrol was chosen to lead six projects aimed at greening and digitalizing air ...

A federal grand jury returned additional indictments charging 31 individuals for a conspiracy to steal millions of dollars from ATMs across the U.S., with a majority of the defendants being affiliated ...

The company revealed Tuesday morning that it has established the capacity to sell up to $300 million in common stock at its sole discretion. This program is pursuant to a shelf registration statement ...

Strive (ASST), a bitcoin BTC $89,320.17 treasury company, saw its perpetual preferred equity (SATA) reach par value of $100 for the first time on Friday, a level that allows it to sell more of the ...

Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- (TSX: DGS, DGS.PR.A) Dividend Growth Split Corp. (the “Fund”) is ...

BROOKFIELD, News, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Brookfield Renewable Corporation (NYSE: BEPC; TSX: BEPC) (“BEPC”) and Brookfield Renewable Partners L.P. (NYSE ...

TORONTO--(BUSINESS WIRE)-- Cybin Inc. (CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to advancing mental healthcare by developing new and innovative ...

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to advancing mental ...